| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.0008 | 1 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00075 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.00076 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.00089 | 1 |